OM Investors Have Opportunity to Join Outset Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Outset released its second quarter 2024 financial results on August 7, 2024. The Company missed consensus estimates by a considerable margin and lowered its full year 2024 outlook. According to the Company, the “changes [it] needs to make are entirely in [its] control” and will involve “shifts and adjustments” to its sales team and processes. Based on this news, shares of Outset fell by 68.53% on August 8, 2024.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com
